Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
Corresponding Author
Stephen H. Caldwell
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Division of Gastroenterology and Hepatology, Box 145, University of Virginia Health Sciences Center, Charlottesville, VA 22908. fax: (804) 924-0491===Search for more papers by this authorDavid H. Oelsner
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorJulia C. Iezzoni
Department of Pathology, University of Virginia, Charlottesville, VA
Search for more papers by this authorElizabeth E. Hespenheide
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorEmily H. Battle
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorCarolyn J. Driscoll
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorCorresponding Author
Stephen H. Caldwell
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Division of Gastroenterology and Hepatology, Box 145, University of Virginia Health Sciences Center, Charlottesville, VA 22908. fax: (804) 924-0491===Search for more papers by this authorDavid H. Oelsner
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorJulia C. Iezzoni
Department of Pathology, University of Virginia, Charlottesville, VA
Search for more papers by this authorElizabeth E. Hespenheide
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorEmily H. Battle
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorCarolyn J. Driscoll
Department of Internal Medicine, Division of Gastroenterology University of Virginia, Charlottesville, VA
Search for more papers by this authorAbstract
We characterized 70 consecutive patients with cryptogenic cirrhosis to assess major risks for liver disease. Each patient was reevaluated for past alcohol exposure, scored by the International Autoimmune Hepatitis (IAH) score and assessed for viral hepatitis risks and risks for nonalcoholic steatohepatitis (NASH). The results were compared with 50 consecutive NASH patients, 39 nonalcoholic patients age 50 and over with cirrhosis from hepatitis C, and 33 consecutive patients with cirrhosis caused by primary biliary cirrhosis (PBC). Among the cryptogenic group, 49 (70%) were female, and the mean age was 63 ± 11 years. Although ascites and variceal bleeding were common, almost one half lacked major signs of complicated portal hypertension. A history of Type 2 diabetes mellitus and/or obesity was present in 51 (73%). Nineteen (27%) patients had a history of blood transfusions antedating the diagnosis of cirrhosis. No clinical or histological features distinguished this group from the other patients, and 14 (74%) of these had a history of obesity and/or diabetes. Nineteen of the remaining nontransfused patients had indeterminant IAH scores but were histologically and biochemically indistinguishable from the others. Twelve of these (63%) also had a history of obesity and/or diabetes. Both diabetes and obesity were significantly more common in the cryptogenic cirrhotic patients compared with the cirrhotic patients with PBC or hepatitis C. In contrast, the prevalence of obesity and diabetes was similar to the NASH patients who were, on average, a decade younger. Although there is some diversity that indicates more than one cause, our findings suggest that NASH plays an under-recognized role in many patients with cryptogenic cirrhosis, most of whom are older, type 2 diabetic and obese females.
References
- 1 Kodali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, non-C hepatitis. Am J Gastroenterol 1994; 89: 1836–1839.MEDLINE
- 2 Saunders JB, Walters JR, Davies AP, Paton A. A twenty year prospective study of cirrhosis. Br Med J 1981; 282: 263–266.
- 3 Powell EE, Graham W, Cooklsey E, Hanson R, Searle J, Halliday J, Powell L. The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74–80.MEDLINE
- 4 Eigenbrodt ML, McCashland TM, Dy RM, Clark J, Galati J. Heterozygous alpha-1 antitrypsin phenotypes in patients with endstage liver disease. Am J Gastroenterol 1997; 92: 602–607.MEDLINE
- 5 Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 1989; 9: 193–197.MEDLINE
- 6 Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994; 21: 866–871.MEDLINE
- 7 Alter MJ, Hadler SC, Judson FN, Mares A, Alexander JW, Hu PY, Miller JK, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231–2235.MEDLINE
- 8 Koretz RL, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis. Ann Intern Med 1993; 119: 110–115.MEDLINE
- 9 Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997; 126: 137–145.MEDLINE
- 10 Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103–1109.MEDLINE
- 11 Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis. J Clin Gastroenterol 1995; 20: 127–130.MEDLINE
- 12 Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989; 20: 594–598.MEDLINE
- 13 Nagore N, Scheuer PJ. The pathology of diabetic hepatitis. J Pathol 1998; 156: 155–160.
- 14 Oelsner DH, Caldwell SH, Kim JP, Yun A. Hepatitis G virus prevalence in a cryptogenic cirrhotic population. Gastroenterology 110: 155–160.
- 15 Linnen J, Wages J, Zhang-Keck Z, Fry KE, Krawczynski KZ, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505–508.MEDLINE
- 16 Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992; 103: 1290–1295.MEDLINE
- 17 Greve M. Ferrell L, Kim M, Combs C, Roberts J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune process. Hepatology 1993; 17: 593–598.MEDLINE
- 18 Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18: 593–598.
- 19 Williamson DF. Descriptive epidemiology of body weight and weight change in U.S. adults. Ann Intern Med 1993; 119: 646–649.MEDLINE
- 20 Kuczmarski RJ. Prevalence of overweight and weight gain in the United States. Am J Clin Nutr 1992; 55: 494S–502S.
- 21 Bray GA. Pathophysiology of obesity. Am J Clin Nutr 1992; 55: 488S–494S.MEDLINE
- 22 McCullough AJ, Mullen KD, Smanik EJ, Tabbaa M, Szauter K. Nutritional therapy and liver disease. Gastroenterol Clin North Am 1989; 18: 619–637.MEDLINE
- 23 Lowell JA. Nutritional assessment and therapy in patients requiring liver transplantation. Liver Transplant Surg 1996; 2: 79–88.
- 24 Launer LJ, Harris T, Rumpel C, Madans J. Body mass index, weight change, and risk of mobility disability in middle-aged and older women. JAMA 1994; 271: 1093–1098.MEDLINE
- 25 Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106–1110.MEDLINE
- 26 Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409–1417.MEDLINE
- 27 Lee RG. Nonalcoholic steatohepatitis: tightening the morphologic screws on a hepatic rambler. Hepatology 1995; 21: 1742–1743.MEDLINE
- 28 French SW. Present understanding of the development of Mallory's body. Arch Pathol Lab Med 1983; 107: 445–450.MEDLINE
- 29 George DK, Goldwurm S, McDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311–318.MEDLINE
- 30 Manns MP, Kruger M. Immunogenetics of chronic liver disease. Gastroenterology 1994; 106: 1676–1697.MEDLINE
- 31 Everhardt JE. Digestive diseases and diabetes. Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health, 457–479.
- 32 DiBisceglie AM, Bacon BR, Neuschwander-Tetri BA, Yun A, Kim JP. Role of hepatitis G virus in cryptogenic liver disease. Gastroenterology 110: 1676–1697.
- 33 Strauss E, Lacet CMC, Caly WR, Fukushima JT, Gayotta LCC. Cryptogenic cirrhosis: clinical-biochemical comparison with alcoholic and viral etiologies. Arch Gastroenerol 1990; 27: 46–52.
- 34
Bloodworth JMB.
Diabetes mellitus and cirrhosis of the liver.
Arch Intern Med
1961;
108: 95–101.
10.1001/archinte.1961.03620110035006 Google Scholar
- 35 Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine 1962; 41: 249–278.
- 36 Itoh S, Youngel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 1987; 82: 650–654.MEDLINE
- 37 Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis. Mayo Clin Proc 1980; 55: 434–438.MEDLINE
- 38 Diehl AM, Goodman Z, Ishak KG. Alcohol-like disease in nonalcoholics. Gastroenterology 1988; 95: 1056–1062.MEDLINE
- 39 Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979; 67: 811–816.MEDLINE
- 40 Barnes RE, Meyer RA, Gordon SC. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community. Am J Gastroenerol 1992; 87: 1001–1004.
- 41 Kenny SJ, Aubert RE, Geiss LS. Prevalence and incidence of non–insulin-dependent diabetes. In: Diabetes in America, 2nd ed. Bethesda, MD: National Institutes of Health, pp 47–67.
- 42 Kuczmarski RJ. Personal communication.
- 43 Pessoa MG, Terrault NA, Ferrell LD, Kim JP, Kolberg J, Detmer J, Collins ML, et al. Hepatitis G virus in patients with cryptogeic liver disease undergoing liver transplantation. Hepatology 1997; 25: 1266–1270.MEDLINE
- 44 Fried MW, Khudyakov YE, Smallwood GA, Cong M, Nicholas B, Diaz E, Siefart P, et al. Hepatitis G virus co-infection in liver transplantation recipients which chronic hepatitis C and non-viral chronic liver disease. Hepatology 1997; 25: 1271–1275.MEDLINE
- 45 Theodore D, Lemon SM. GB virus C, hepatitis G virus, or human orphan flavivirus? Hepatology 1997; 25: 1285–1286.MEDLINE
- 46 Tumiel M, Whitcomb BJ, Krawitt EL. Circulating antinuclear antibodies in patients with nonalcoholic steatohepatitis. Hepatology 20: 1285–1286.
- 47 Czaja AJ, Santrach PJ, Moore SB. HLA-DQ associations in Type 1 autoimmune hepatitis. Mayo Clin Proc 1995; 70: 1154–1160.MEDLINE
- 48 Maddrey WC, Iber FL. Familial cirrhosis. A clinical and pathologic study. Ann Intern Med 1964; 61: 667–679.
- 49 Schaffner F, Popper H. Capillarization of hepatic sinusoids. Gastroenterology 1963; 44: 239–242.
- 50 Nosadini R, Avogaro A, Mollo F, Marescotti C, Tiengo A, Duner E, et al. Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. J Clin Endocrinol Metab 1984; 58: 1125–1132.MEDLINE
- 51 Matsui O, Kadoya M, Takahashi S, Yoshikawa J, Gabata T, Takashima T, Kitagawa K. Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage. Am J Roentgenol 1995; 164: 1137–1140.
- 52 Day CP, James OFW. Hepatic steatosis: innocent bystander or guilty party? Hepatology 1998; 27: 1463–1466.MEDLINE